Albireo

Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation

Older News

GOTHENBURG, Sweden, November 18 - Albireo today announced the completion of a phase 1b study showing a favourable tolerability and safety profile of A3309 in patients with chronic idiopathic constipation.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy